Orion Pharma Limited announced consolidated unaudited earnings results for the first quarter ended September 30, 2017. For the quarter, the company reported EPS was BDT 1.10 against BDT 1.17 a year ago. NOCFPS was BDT 2.53 against BDT 1.33 a year ago. NAV per share (including revaluation surplus) was BDT 72.05 against BDT 71.09 a year ago. NAV per share (excluding revaluation surplus) was BDT 63.62 against BDT 62.51 a year ago.